Compare · ADVB vs CI
ADVB vs CI
Side-by-side comparison of Advanced Biomed Inc. (ADVB) and The Cigna Group (CI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ADVB and CI operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $73.81B, about 4866.5x ADVB ($15.2M).
- Over the past year, ADVB is down 0.5% and CI is down 6.9% - ADVB leads by 6.5 points.
- CI has been more active in the news (7 items in the past 4 weeks vs 1 for ADVB).
- CI has more recent analyst coverage (25 ratings vs 0 for ADVB).
- Company
- Advanced Biomed Inc.
- The Cigna Group
- Price
- $8.96+14.87%
- $279.37-0.35%
- Market cap
- $15.2M
- $73.81B
- 1M return
- -37.03%
- -3.98%
- 1Y return
- -0.47%
- -6.93%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 1
- 7
- Recent ratings
- 0
- 25
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest ADVB
- Large owner Pau Hung To disposed of $84,588,000,000 worth of Common Stock par vlaue $0.001 (176,225 units at $480,000.00), closing all direct ownership in the company (SEC Form 4)
- SEC Form RW filed by Advanced Biomed Inc.
- Advanced Biomed Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits
- Advanced Biomed Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form DEF 14A filed by Advanced Biomed Inc.
- SEC Form 10-Q filed by Advanced Biomed Inc.
- Advanced Biomed Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Latest CI
- SEC Form 4 filed by Officer Holgerson Bryan
- Officer Jones Nicole S sold $748,516 worth of shares (2,677 units at $279.61) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 25,880 units (SEC Form 4)
- SEC Form 144 filed by The Cigna Group
- Officer Jones Nicole S exercised 15,346 shares at a strike of $192.02 and sold $5,369,584 worth of shares (19,436 units at $276.27) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 28,557 units (SEC Form 4)
- SEC Form 144 filed by The Cigna Group
- The Cigna Group downgraded by Jefferies with a new price target
- The Cigna Group downgraded by Raymond James with a new price target
- SEC Form 10-Q filed by The Cigna Group
- The Cigna Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook